About
Technology
Issues
FAQ
Links
Official Page
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.